||5R01CA222833-02 Interpret this number
||Fred Hutchinson Cancer Research Center
||Statistical Genetics and Genomics for Epidemiologic Research
Genome-wide association studies have identified an unprecedented number of genetic variants associated with disease
risk, yet molecular mechanisms and clinical implications of genetic risk alleles are largely unknown. Epidemiologic
research is extending its reach to more translational and mechanistic studies, integrating genetic risk variants with
environmental exposures, interventions, gene expression and epigenetics. Motivated by population-based studies for
prostate cancer research, we will develop statistical methods for emerging translational topics: how to search for
genotypes that predict individual and subgroup intervention effects? how to identify epigenetic alterations that may be
an interface of the environment and the genome? how to assess causal mediation effect of a modifiable risk factor or
a molecular alteration in relation to disease outcomes? These topics present unmet statistical challenges because of
high dimensionality and complex modeling. Specific statistical methods to be developed include high-dimensional gene-
treatment interaction, multi-locus regional association, mediation analyses, instrumental variable analyses, Mendelian
randomization, and shrinkage and regularization.
The methodological research in this project is driven primarily by prostate cancer, the most common noncutaneous
cancer and the second leading cause of cancer death in American men, a ecting one in six in his lifetime. This project
nests in highly-accomplished consortium studies (PCPT/SELECT/PRACTICAL/PCPS), all of which have generated
far-reaching impact on prostate cancer research. The unique feature of this project is that methodological development
will be seamlessly integrated with ongoing analyses, ensuring immediate translation. Our transdisciplinary research
team has been actively engaged in statistical genetics and genomics, and conducting molecular epidemiological studies.
The PI brings a wealth of expertise in high-dimensional methods, molecular biomarkers, and genetic epidemiology. This
project will have a far-reaching impact on methodologies in cancer etiology, prevention, and treatment outcomes.
Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.
, LeBlanc M.
, Goodman P.J.
, Lucia M.S.
, Thompson I.M.
, Tangen C.M.
Cancer prevention research (Philadelphia, Pa.), 2019 Feb; 12(2), p. 113-120.
Vigorous Physical Activity Is Associated with Lower Risk of Metastatic-Lethal Progression in Prostate Cancer and Hypomethylation in the CRACR2A Gene.
, Wang B.
, Wang X.
, Cheng A.
, Kolb S.
, Stanford J.L.
, Wright J.L.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019 Feb; 28(2), p. 258-264.
Diagnostics for Pleiotropy in Mendelian Randomization Studies: Global and Individual Tests for Direct Effects.
, Peters U.
, Wang X.
, Kocarnik J.
, Chang-Claude J.
, Slattery M.L.
, Chan A.
, Lemire M.
, Berndt S.I.
, Casey G.
, et al.
American journal of epidemiology, 2018-12-01; 187(12), p. 2672-2680.